# Autologous Bone Marrow Stem Cell Transplantation in Patients With Subacute Spinal Cord Injury

> **NCT05671796** · PHASE2 · UNKNOWN · sponsor: **SENAI CIMATEC** · enrollment: 40 (estimated)

## Conditions studied

- Spinal Cord Injuries

## Interventions

- **GENETIC:** Mesenchymal stem cell transplantation
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05671796
- **Lead sponsor:** SENAI CIMATEC
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-01
- **Primary completion:** 2023-09-25
- **Final completion:** 2023-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-01-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05671796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05671796, "Autologous Bone Marrow Stem Cell Transplantation in Patients With Subacute Spinal Cord Injury". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05671796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*